Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
21 6월 2023 - 7:10PM
Edgar (US Regulatory)
UNITED STATES SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________
FORM 6-K
________________________
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of June 2023
Commission File Number: 001-38281
________________________
ERYTECH Pharma S.A.
(Translation of registrant’s name into English)
________________________
60 Avenue Rockefeller
69008 Lyon France
(Address of principal executive office)
________________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F S Form 40-F £
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
Press release
On June 20, 2023, ERYTECH Pharma S.A. issued a press release to announce the filing of a new lawsuit by Akkadian Partners.
The full text of the press release is attached as Exhibit 99.1 to this Report on Form 6-K and incorporated herein by reference.
EXHIBIT INDEX
| | | | | | | | |
| Exhibit | | Description |
| |
| 99.1 | | Press Release dated June 20, 2023. |
| |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | | | | | | | | | | | | | | | | | |
| | | | | | |
| | | | ERYTECH Pharma S.A. |
| | | |
Date: | June 21, 2023 | | | By: | | /s/ Eric Soyer |
| | | | | | Name Eric Soyer |
| | | | | | Title: Chief Financial Officer and Chief Operating Officer |
Erytech Pharma (NASDAQ:ERYP)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Erytech Pharma (NASDAQ:ERYP)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
